Press release Biocartis NV: Invitation to the Special Shareholders’ Meeting

NEXT STORY
Basilea announces completion of patient enrolment in phase 1 study with oral BAL101553 in brain cancer
PREV STORY
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech berichtet über Entwicklungen im dritten Quartal 2018

Unternehmen stellt aktualisierte Übersicht zur klinischen und Entdeckungs-Pipeline sowie anderen Unternehmensinitiativen vor AUSTIN, Texas, ...

author_avatar
NASDAQ Market News

Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms

SALT LAKE CITY and GAITHERSBURG, Md., Oct. 27, 2016 (GLOBE NEWSWIRE) -- A first-of-its-kind ...

author_avatar
NASDAQ Market News

resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development

Newly Created Position Strategically Expands Development CapabilitiesBOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- resTORbio, ...

author_avatar
NASDAQ Market News